Anthem Nears Deal to Acquire Cigna for $48 Billion

Anthem Inc. is nearing a deal to buy Cigna Corp. for more than $48 billion in a transaction that, alongside another recent proposed tie-up of rivals, would reduce the number of companies atop the U.S. health-insurance industry to three from five.

Anthem is expected to pay about $187 a share for Cigna , according to people familiar with the matter. A deal between the two companies could be announced as soon as Thursday afternoon, one of them said. The combination still hasn’t been signed and the timing could slip and terms could change.

An Anthem-Cigna tie-up would continue a rapid-fire attempted reconfiguration of the top echelon of the managed-care industry, which provides a vital service to vast swaths of the American population. The biggest players are seeking cost efficiency and scale as the health-care landscape changes dramatically as a result of the Affordable Care Act and other factors.

The deal would follow by about three weeks an agreement by Aetna Inc. to buy Humana Inc. for $34 billion. In a sign of the takeover frenzy among the companies, Cigna had also been vying for Humana, but failed to arrange the cash-heavy offer that Humana had requested, according to people familiar with the matter. The only company among the five major health insurers that is sitting out this merger wave, at least so far, is UnitedHealth Group Inc. , the largest by revenue.

There is no guarantee regulators would bless either union, and indeed legal experts have said they would likely take a close look at both.

An expanded version of this report appears at

Recommended Articles

White House Leaves One Trump-Era Policy Alone

The Biden administration has gutted many of former President Donald Trump’s health care policies, but there’s one that the White House has yet to touch, Kelly reports. It’s a 2019 rule that expanded individual coverage health reimbursement arrangements, or ICHRAs, which allowed employers to provide tax-exempt subsidies to help workers purchase Obamacare plans. The Biden administration’s ...

Read More

Court Strikes Down HHS Rule that Allowed Insurers to Not Count Copay Assistance

In a major victory for patients who depend on prescription drugs, Judge John D. Bates of the U.S. District Court for the District of Columbia struck down a Trump administration federal rule that allowed health insurers to not count drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs. The case was brought against the U.S. Department of Health and ...

Read More

Lawmakers, Payers And Providers All Air Grievances With Federal No Surprises Act Implementation

Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act and throw their support behind court-ordered rewrites of independent dispute resolution (IDR) regulations. During a hearing exploring the “flawed implementation” of the law intended ...

Read More

As Biden Plans To Ban Medical Debt From Credit Scores, Advocates Press For More Change

The dramatic impact of medical debt on credit scores may soon be a thing of the past. On Thursday, the White House announced a plan outlined by the Consumer Financial Protection Bureau (CFPB) to eliminate medical debt from credit reports. The move — which follows an earlier decision from the three main credit bureaus to eliminate paid medical debt, medical ...

Read More